Skip to search formSkip to main contentSkip to account menu

Lyxumia

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lixisenatide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Combined insulin/GLP-1 pens near market
Highly Cited
2015
Highly Cited
2015
Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis.
2014
2014
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices
Background: Glucagon-like peptide-1 (GLP-1) receptor agonists are a relatively recent addition to the treatment options for type… 
2014
2014
Le medicament du mois. Le lixisenatide (Lyxumia): nouvel agoniste des recepteurs du glucagon-like peptide-1 a action preferentiellement post-prandiale.
Rev Med Liège 2014; 69 : 2 : 102-109 Résumé : Le lixisénatide (Lyxumia) est un nouvel agoniste des récepteurs du Glucagon-Like… 
Review
2014
Review
2014
Lixisenatide (Lyxumia): new GLP‐1 mimetic for type 2 diabetes
Lixisenatide is a new GLP‐1 mimetic for use in type 2 diabetes with oral agents and/or insulin. In our New products review, Steve… 
2014
2014
[Lixisenatide (Lyxumia), a new agonist of glucagon-like peptide-1 receptors with a predominant postprandial action].
: Lixisenatide (Lyxumia) is a new agonist of Glucagon-Like Peptide-1 (GLP-1) receptors that is indicated in the treatment of type… 
2014
2014
[Lixisenatide (Lyxumia), subcutaneous].
2013
2013
Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
The glucagon-like peptide (GLP)-1 receptor agonist lixisenatide (Lyxumia®) was approved for marketing by the European Medicines… 
Review
2013
Review
2013
Lixisenatide: First Global Approval
The selective once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist lixisenatide (Lyxumia®) is under development… 
Review
2013
Review
2013
Lixisenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
Lixisenatide (Lyxumia®) is a glucagon-like peptide-1 receptor agonist that acts in a glucose-dependent manner to improve glycemic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)